Back to results
US 2026/0232792 A1Published application
Cpg oligonucleotide and use thereof
AssigneeParr Biotechnology (Hebei) Co., Ltd.
InventorLigong WANG
Life of this patent
Estimating the term…
Abstract
A CpG oligonucleotide and use of the CpG oligonucleotide are described. The CpG oligonucleotide has TLR9 agonist activity.
Claims48
A CpG oligonucleotide having a sequence as set forth in SEQ ID NO:
- 1.
31-38. (canceled)
(canceled)
Dependencies are inferred from the claim text.